Gene · 90
Papers2,859
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 2,859
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Momelotinib: an emerging treatment for myelofibrosis patients with anemia. | J Hematol Oncol | 2022 | 35045875 | PubTator, text mining | PubMed |
| The versatility and paradox of BMP signaling in endothelial cell behaviors and blood vessel function. | Cell Mol Life Sci | 2022 | 35044529 | PubTator, text mining | PubMed |
| Uncoupling the BMP receptor antagonist function from the WNT agonist function of R-spondin 2 using the inhibitory peptide dendrimer RWd. | J Biol Chem | 2022 | 35032551 | PubTator, text mining | PubMed |
| Dynamics of skeletal muscle-resident stem cells during myogenesis in fibrodysplasia ossificans progressiva. | NPJ Regen Med | 2022 | 35031614 | PubTator, text mining | PubMed |
| Evaluation of Substituted Pyrazole-Based Kinase Inhibitors in One Decade (2011-2020): Current Status and Future Prospects. | Molecules | 2022 | 35011562 | PubTator, text mining | PubMed |
| Identification of a novel mutation in the BMPR2 gene in a pulmonary arterial hypertension patient using next-generation sequencing. | J Clin Lab Anal | 2022 | 34953004 | PubTator, text mining | PubMed |
| Myelofibrosis: Genetic Characteristics and the Emerging Therapeutic Landscape. | Cancer Res | 2022 | 34911786 | PubTator, text mining | PubMed |
| Extensive progressive heterotopic ossification post-Covid-19 in a man. | Bone | 2022 | 34896358 | PubTator, text mining | PubMed |
| Integrated genome and tissue engineering enables screening of cancer vulnerabilities in physiologically relevant perfusable ex vivo cultures. | Biomaterials | 2022 | 34890975 | PubTator, text mining | PubMed |
| Endothelial k-RasV12 Expression Induces Capillary Deficiency Attributable to Marked Tube Network Expansion Coupled to Reduced Pericytes and Basement Membranes. | Arterioscler Thromb Vasc Biol | 2022 | 34879709 | PubTator, text mining | PubMed |
| Pregnancy, preeclampsia and maternal aging: From epidemiology to functional genomics. | Ageing Res Rev | 2022 | 34871806 | PubTator, text mining | PubMed |
| An ACVR1R375P pathogenic variant in two families with mild fibrodysplasia ossificans progressiva. | Am J Med Genet A | 2022 | 34854557 | PubTator, text mining | PubMed |
| Identification of liver-derived bone morphogenetic protein (BMP)-9 as a potential new candidate for treatment of colorectal cancer. | J Cell Mol Med | 2022 | 34841646 | PubTator, text mining | PubMed |
| Hypo-trimethylation of Histone H3 Lysine 4 and Hyper-tri/dimethylation of Histone H3 Lysine 27 as Epigenetic Markers of Poor Prognosis in Patients with Primary Central Nervous System Lymphoma. | Cancer Res Treat | 2022 | 34793663 | PubTator, text mining | PubMed |
| Inhibition of ALK2 with bicyclic pyridyllactams. | Bioorg Med Chem Lett | 2022 | 34780900 | PubTator, text mining | PubMed |
| EZHIP: a new piece of the puzzle towards understanding pediatric posterior fossa ependymoma. | Acta Neuropathol | 2022 | 34762160 | PubTator, text mining | PubMed |
| Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies. | Oncogene | 2022 | 34759345 | PubTator, text mining | PubMed |
| Whole exome sequencing reveals potentially pathogenic variants in a small subset of premenopausal women with idiopathic osteoporosis. | Bone | 2022 | 34743040 | PubTator, text mining | PubMed |
| Single-Cell Atlas of Lineage States, Tumor Microenvironment, and Subtype-Specific Expression Programs in Gastric Cancer. | Cancer Discov | 2022 | 34642171 | PubTator, text mining | PubMed |
| Clearance of Senescent Cells From Injured Muscle Abrogates Heterotopic Ossification in Mouse Models of Fibrodysplasia Ossificans Progressiva. | J Bone Miner Res | 2022 | 34633114 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/90/papers?page=37